Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity

Significance After influenza A virus infection, the host is protected from subsequent unrelated respiratory virus infections for a temporary period. Although this phenomenon has been reported both in animal models and human clinical data, the mechanism for this antiviral immunity is incompletely understood. In this article, we demonstrate that club cells surviving direct infection by influenza A virus are reprogramed to promote an antiviral lung environment, and the depletion of “survivor cells” eliminates the postinfluenza window of nonspecific immunity. These findings demonstrate a type of immunity that does not fit into the classical innate or adaptive models and may inform the future designs of vaccines, where eliciting nonspecific immunity would be beneficial. A brief window of antigen-nonspecific protection has been observed after influenza A virus (IAV) infection. Although this temporary immunity has been assumed to be the result of residual nonspecific inflammation, this period of induced immunity has not been fully studied. Because IAV has long been characterized as a cytopathic virus (based on its ability to rapidly lyse most cell types in culture), it has been a forgone conclusion that directly infected cells could not be contributing to this effect. Using a Cre recombinase-expressing IAV, we have previously shown that club cells can survive direct viral infection. We show here not only that these cells can eliminate all traces of the virus and survive but also that they acquire a heightened antiviral response phenotype after surviving. Moreover, we experimentally demonstrate temporary nonspecific viral immunity after IAV infection and show that surviving cells are required for this phenotype. This work characterizes a virally induced modulation of the innate immune response that may represent a new mechanism to prevent viral diseases.

[1]  J. Schenkel,et al.  Resident memory CD8 T cells trigger protective innate and adaptive immune responses , 2014, Science.

[2]  R. Hai,et al.  Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies , 2013, Journal of Virology.

[3]  David Artis,et al.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus , 2011, Nature Immunology.

[4]  A. Iwasaki,et al.  Tissue‐resident memory T cells , 2013, Immunological reviews.

[5]  H. Kelly,et al.  Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  Christopher M Waters,et al.  Epithelial repair mechanisms in the lung. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[7]  Pedro A Piedra,et al.  Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial , 2005, Pediatrics.

[8]  William Stafford Noble,et al.  Matrix2png: a utility for visualizing matrix data , 2003, Bioinform..

[9]  B. Lina,et al.  Impact of the 2009 influenza A(H1N1) pandemic wave on the pattern of hibernal respiratory virus epidemics, France, 2009. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  Gerhard Walzl,et al.  Influenza Virus Lung Infection Protects from Respiratory Syncytial Virus–Induced Immunopathology , 2000, The Journal of experimental medicine.

[11]  Elizabeth A. Calle,et al.  Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. , 2014, Cell stem cell.

[12]  Xinyu Wang,et al.  The role of airway epithelial cells and innate immune cells in chronic respiratory disease , 2014, Nature Reviews Immunology.

[13]  N. Ferguson,et al.  Ecological and immunological determinants of influenza evolution , 2003, Nature.

[14]  W. Lim,et al.  The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009–2011 , 2012, Influenza and other respiratory viruses.

[15]  Benjamin J Cowling,et al.  Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. , 2012, Epidemiology.

[16]  James M. McCaw,et al.  Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model , 2015, The Journal of infectious diseases.

[17]  Kim L Kusser,et al.  Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity , 2004, Nature Medicine.

[18]  M. J. Evans,et al.  Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies , 2013, PLoS pathogens.

[19]  L. Lefrançois,et al.  Regional and mucosal memory T cells , 2011, Nature Immunology.

[20]  S. Hirsh,et al.  Epidemiological Changes of Respiratory Syncytial Virus (RSV) Infections in Israel , 2014, PloS one.

[21]  P. Doherty,et al.  A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.

[22]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[23]  Steffen Jung,et al.  A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration , 2005, Nature Methods.

[24]  N. Heaton,et al.  Long-term survival of influenza virus infected club cells drives immunopathology , 2014, The Journal of experimental medicine.

[25]  B. Cowling,et al.  Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Mintern,et al.  Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3 , 2013, Nature Immunology.

[27]  B. Yahaya Understanding Cellular Mechanisms Underlying Airway Epithelial Repair: Selecting the Most Appropriate Animal Models , 2012, TheScientificWorldJournal.

[28]  I. Donatelli,et al.  Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. , 2005, Vaccine.

[29]  L. Montoliu,et al.  Binary recombinase systems for high-resolution conditional mutagenesis , 2014, Nucleic acids research.

[30]  Deborah Middleton,et al.  Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. , 2010, The Journal of infectious diseases.

[31]  M. Netea,et al.  Innate immune memory: towards a better understanding of host defense mechanisms. , 2014, Current opinion in immunology.